[1]. [1]Diaz-Avalos R, Long C, Fontano E, Balbirnie M, Grothe R, Eisenberg D, et al. Cross-beta order and diversity in nanocrystals of an amyloid-forming peptide. J. Mol. Biol. 2003;330:1165–1175. MEDLINE |
CrossRef
[2]. [2]Nelson R, Sawaya MR, Balbirnie M, Madsen AO, Riekel C, Grothe R, et al. Structure of the cross-b spine of amyloid-like fibrils. Nature. 2005;435:773–778.
CrossRef
[3]. [3]Dobson CM. Protein misfolding, evolution and disease. Trends Biochem. Sci. 2002;24:329–332. MEDLINE |
CrossRef
[4]. [4]Anderson M, Bocharova OV, Makarava N, Breydo L, Salnikov VV, Baskakov IV. Polymorphism and ultrastructural organization of prion protein amyloid fibrils: an insight from high resolution atomic force microscopy. J. Mol. Biol. 2006;358:580–596. MEDLINE |
CrossRef
[5]. [5]Tycko R. Molecular structure of amyloid fibrils: insights from solid-state NMR. Quart. Rev. Biophys. 2006;1–55.
[6]. [6]Petkova AT, Leapman RD, Gua Z, Yau W-M, Mattson MP, Tycko R. Self-propagating, molecular-level polymorphism in Alzheimer’s b-amyloid fibrils. Science. 2005;307:262–265.
CrossRef
[7]. [7]Makarava N, Baskakov IV. The same primary structure of the prion protein yields two distinct self-propagating states. J. Biol. Chem. 2008;283:15988–15996.
CrossRef
[8]. [8]Chien P, Weissman JS, DePace AH. Emerging principles of conformation-based prion inheritance. Annu. Rev. Biochem. 2004;73:617–656. MEDLINE |
CrossRef
[9]. [9]Si K, Lindquist S, Kandel ER. A nauronal isoform of the aplysia CPEB has prion-like properties. Cell. 2003;115:879–891. MEDLINE |
CrossRef
[10]. [10]Wickner RB, Taylor KL, Edskes HK, Maddelein ML, Moriyama H, Roberts BT. Yeast prions act as genes composed of self-propagating protein amyloids. Adv. Protein Chem. 2001;57:313–314. MEDLINE |
CrossRef
[11]. [11]Makarava N, Ostapchenko VG, Savtchenko R, Baskakov IV. Conformational switching within individual amyloid fibrils. J. Biol. Chem. 2009;284:14386–14395.
CrossRef
[12]. [12]Baskakov IV, Bocharova OV. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry. 2005;44:2339–2348.
[13]. [13]Eisenberg D, Nelson R, Sawaya MR, Balbirnie M, Sambashivan S, Ivanova MI, et al. The structural biology of protein aggregation diseases: fundamental questions and some answers. Acc. Chem. Res. 2006;39:568–575. MEDLINE |
CrossRef
[14]. [14]Makarava N, Lee CI, Ostapchenko VG, Baskakov IV. Highly promiscuous nature of prion polymerization. J. Biol. Chem. 2007;282:36704–36713.
CrossRef
[15]. [15]Shashilov, V., Xu, M., Makarava, N., Savtchenko, R., Baskakov, I.V. and Lednev, I.K. (submitted for publication) Dissecting structure of prion amyloid fibrils by hydrogen–deuterium exchange ultraviolet Raman spectroscopy.
[16]. [16]Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, et al. Prion detection by an amyloid seeding assay. Proc. Acad. Natl. Sci. USA. 2007;104:20914–20919.
[17]. [17]Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, et al. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Method. 2007;4:645–650.
[18]. [18]Bocharova OV, Breydo L, Salnikov VV, Gill AC, Baskakov IV. Synthetic prions generated in vitro are similar to a newly identified subpopulation of PrPSc from sporadic Creutzfeldt–Jakob Disease PrPSc Prot. Science. 2005;14:1222–1232.
[19]. [19]Wille, H., McDonald, M., Bian, W., Kendall, A., Borovinskiy, A., Cohen, F., Prusiner, S. and Stubbs, G. (2008) X-ray fiber diffraction reveals major structural differences between brain-derived prions and recombinant prion protein amyloid. In: Abstracts, International Conference “Prion-2008”, Madrid, Spain, p. 39 (Ref Type: Abstract).
[20]. [20]Peretz D, Scott M, Groth D, Williamson A, Burton D, Cohen FE, et al. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci. 2001;10:854–863. MEDLINE |
CrossRef
[21]. [21]Sun Y, Breydo L, Makarava N, Yang Q, Bocharova OV, Baskakov IV. Site-specific conformational studies of PrP amyloid fibrils revealed two cooperative folding domain within amyloid structure. J. Biol. Chem. 2007;282:9090–9097. MEDLINE |
CrossRef
[22]. [22]Legname G, Nguyen H-OB, Baskakov IV, Cohen FE, DeArmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc. Natl. Acad. Sci. USA. 2005;102:2168–2173. MEDLINE |
CrossRef
[23]. [23]Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in b-sheet conformations of abnormal prion protein. J. Biol. Chem. 1998;273:32230–32235. MEDLINE |
CrossRef
[24]. [24]Thomzig A, Spassov S, Friedrich M, Naumann D, Beekes M. Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J. Biol. Chem. 2004;279:33854.
[25]. [25]Legname G, Nguyen H-OB, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc. Acad. Natl. Sci. USA. 2006;103:19105–19110.
[26]. [26]Baskakov IV, Breydo L. Converting the prion protein: what makes the protein infectious. Biochim. Biophys. Acta (Molecular Basis of Disease). 2007;1772:692–703.
[27]. [27]Chesebro B, Trifilo M, Race M, Meade-White K, Teng C, LaCasse R, et al. Anchorless prion protein result in infectious amyloid disease without clinical scrapie. Science. 2005;308:1435–1439.
CrossRef
[28]. [28]Tuzi NL, Cancellotti E, Baybutt H, Blackford L, Bradford B, Plinston C, et al. Host PrP glycosylation: a major factor determining the outcome of prion infection. PLOS Biol. 2008;6:e100.
CrossRef
[29]. [29]Lu KP. Pinning down cell signaling, cancer and Alzheimer’s disease. Trends Biochem. Sci. 2004;29:200–209. MEDLINE |
CrossRef
[30]. [30]Cohen E, Taraboulos A. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J. 2003;22:404–417. MEDLINE |
CrossRef
[31]. [31]Eakin CM, Berman AJ, Miranker AD. A native to amyloidogenic transition regulated by a backbone trigger. Nat. Struct. Mol. Biol. 2006;13:202–208. MEDLINE |
CrossRef
[32]. [32]Capobianco R, Casalone C, Suardi S, Mangieri M, Miccolo C, Limido L, et al. Conversion of the BASE prion strain into BSE strain: the origin of BSE?. PLOS Pathog. 2007;3:e31.
CrossRef
[33]. [33]Peretz D, Williamson RA, Legname G, Matsunaga Y, Vergara J, Burton D, et al. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron. 2002;34:921–932. MEDLINE |
CrossRef
[34]. [34]Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J, Soto C. Crossing the species barrier by PrPSc replication in vitro generates unique infectious prions. Cell. 2008;134:757–768.
CrossRef
[35]. [35]Green KM, Castilla J, Seward TS, Napier DL, Jewell JE, Soto C, et al. Accelerated high fidelity prion amplification within and across prion species barriers. PLOS Pathog. 2008;4:e1000139.
[36]. [36]Nilsson KPR, Aslund A, Berg I, Nystrom S, Konradsson P, Herland A, et al. Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer’s disease using novel luminescent probes. ACS Chem. Biol. 2007;2:553–560.
CrossRef
[37]. [37]Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell. 2001;106:171–182. MEDLINE |
CrossRef
[38]. [38]Derkatch IL, Uptain SM, Quteiro TF, Krishnan R, Lindquist SL, Liebman SW. Effects of Q/N-rich, polyQ, and non-polyQ, amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro. Proc. Acad. Natl. Sci. USA. 2004;101:12934–12939.
[39]. [39]Lundmark K, Westermark GT, Olsen A, Westermark P. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. Proc. Acad. Natl. Sci. USA. 2005;102:6098–6102.
[40]. [40]O’Nuallain B, Williams AD, Westermark P, Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 2004;279:17490–17494. MEDLINE |
CrossRef
[41]. [41]Yan J, Fu X, Ge F, Zhang B, Yao J, Zhang H, et al. Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. Am. J. Pathol. 2007;171:172–180. MEDLINE |
CrossRef
[42]. [42]Vitrenko YA, Gracheva EO, Richmond JE, Liebman SW. Visualisation of aggregation of the Rnq1 prion domain and cross-seeding interactions with Sup35NM. J. Biol. Chem. 2007;282:1779–1787. MEDLINE |
CrossRef
[43]. [43]Meriin AB, Zhang X, Newnam GP, Chernoff YO, Sherman MY. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J. Cell Biol. 2002;157:997–1004. MEDLINE |
CrossRef